TrialBlood advances2022

Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study.

Jun Ho Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.